StockData
Senseonics Holdings, Inc. logo

Senseonics Holdings, Inc. (SENS) shareholders

SENSNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3026% above fair value
$10.16−0.74 (-6.79%)

Close on Nov 17, 2026Market cap $537.20MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
39.4%
21M of 53M shares
Institutional holders
108
42 new, 17 sold out
Net institutional buying
12M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $627.30K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Robert J. Smith
Joint filing with Energy Capital, LLC (6.10%)
50,035,0006.14%13G (passive) amendmentMay 19, 2025
John Petry
Joint filing with Sessa Capital IM, L.P. (9.90%)
12,437,5329.90%13G (passive)Jun 30, 2026
BlackRock, Inc.2,743,2635.20%13G (passive) amendmentSep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SENSValueChange% of portfolio
Sessa Capital IM, L.P.4,437,5328.39%$25.21M+2,671,4390.42%
BlackRock, Inc.2,793,5585.28%$15.87M+2,224,8290.00%
Vanguard Capital Management LLC1,779,3983.37%$10.11M+162,2010.00%
Avidity Partners Management LP1,600,0003.03%$9.09MNew1.46%
Sio Capital Management, LLC1,592,6923.01%$9.05M+1,476,9081.50%
UBS Group AG1,487,4292.81%$8.45M+1,039,2000.00%
Geode Capital Management, LLC1,132,2102.14%$6.43M+665,6950.00%
Masters Capital Management LLC700,0001.32%$3.98M+200,0000.10%
State Street Corp511,1170.97%$2.90M+330,8360.00%
Marshall Wace, Llp405,6950.77%$2.30M−58,6800.00%
Bank Of America Corp /De/394,4650.75%$2.24M+337,5010.00%
Charles Schwab Investment Management Inc393,2110.74%$2.23M+172,0340.00%
Northern Trust Corp332,2660.63%$1.89M+249,9890.00%
Vanguard Fiduciary Trust Co331,3530.63%$1.88M+106,1860.00%
Walleye Capital LLC324,2640.61%$1.84MNew0.01%
Vanguard Portfolio Management LLC272,3750.52%$1.55MNew0.00%
Goldman Sachs Group Inc231,5090.44%$1.31M+85,2270.00%
Morgan Stanley164,9840.31%$937.11K+41,0410.00%
Russell Investments Group, Ltd.153,2160.29%$870.27K+153,2090.00%
Trexquant Investment LP135,1280.26%$767.53KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202610821M39.4%42 / 3215 / 1713M1M
Q1 2026859M16.6%25 / 1719 / 225M1M
Q4 2025857M12.5%83 / 01 / 56M0M
Q3 202580M0.8%8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

67 funds held SENS in Q2 2026, 79% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of SENSValue% of fundAs of
Vanguard Total Stock Market Index Fund1,175,1902.22%$6.68M0.00%Jun 30, 2026
iShares Russell 2000 ETF972,8101.84%$5.53M0.01%Jun 30, 2026
Vanguard Extended Market Index Fund559,6721.06%$3.18M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund430,0280.81%$2.16M0.01%Jul 31, 2026
iShares Russell 2000 Growth ETF370,5100.70%$2.10M0.01%Jun 30, 2026
Fidelity Extended Market Index Fund184,8050.35%$1.25M0.00%May 31, 2026
Schwab U.S. Small-Cap ETF179,4840.34%$1.22M0.01%May 31, 2026
iShares Micro-Cap ETF132,5090.25%$752.65K0.05%Jun 30, 2026
Schwab Small-Cap Index Fund96,0320.18%$483.04K0.01%Jul 31, 2026
Fidelity Total Market Index Fund74,0260.14%$502.64K0.00%May 31, 2026
Master Small Cap Index Series73,7500.14%$418.90K0.01%Jun 30, 2026
Ultra-Small Company Market Fund62,1000.12%$352.73K0.24%Jun 30, 2026
Fidelity Series Total Market Index Fund57,3160.11%$389.18K0.00%May 31, 2026
Nuveen Small Cap Blend Index Fund52,1330.10%$262.23K0.01%Jul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF51,0990.10%$290.24K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Brian B. HansenChief Commercial Officer, Director119,0870.23%Nov 17, 2026
Francine KaufmanChief Medical Officer, Director166,9890.32%Nov 17, 2026
Timothy T. GoodnowPresident and CEO, Director1,082,5502.05%Nov 17, 2026
Frederick T. SullivanChief Financial Officer211,8720.40%Nov 17, 2026
Kenneth L. HortonGC & Corp. Development Advisor268,6470.51%Nov 17, 2026
Mukul JAINChief Operating Officer470,1760.89%Nov 17, 2026
Douglas A. RoederDirector189,7120.36%Nov 16, 2026
Edward FiorentinoDirector87,3920.17%Oct 5, 2026
Edelman StevenDirector92,3750.17%Oct 5, 2026
Douglas S. PrinceDirector70,1460.13%Oct 5, 2026
Stephen P. DeFalcoDirector111,0190.21%May 21, 2026
Sharon LarkinDirector41,8620.08%May 21, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Frederick T. Sullivan
Chief Financial Officer
Nov 15, 2026Tax withholding−14,605$10.58$154.52K211,872
Francine Kaufman
Chief Medical Officer, Director
Nov 15, 2026Tax withholding−10,068$10.58$106.52K166,989
Mukul JAIN
Chief Operating Officer
Nov 15, 2026Tax withholding−30,687$10.58$324.67K470,176
Timothy T. Goodnow
President and CEO, Director
Nov 15, 2026Tax withholding−61,198$10.58$647.47K1,082,550
Kenneth L. Horton
GC & Corp. Development Advisor
Nov 15, 2026Tax withholding−16,865$10.58$178.43K268,647
Brian B. Hansen
Chief Commercial Officer, Director
Nov 15, 2026Tax withholding−7,850$10.58$83.05K119,087
Douglas A. Roeder
Director
Nov 13, 2026Buy+17,040.716$10.32$175.86K189,712
Edelman Steven
Director
Oct 1, 2026Award+1,292$9.96$12.87K92,375
Douglas S. Prince
Director
Oct 1, 2026Award+815$9.96$8.12K70,146
Edward Fiorentino
Director
Oct 1, 2026Award+1,418$9.96$14.12K87,392
Douglas A. Roeder
Director
Oct 1, 2026Award+1,480$9.96$14.74K172,671
Douglas A. Roeder
Director
Aug 19, 2026Buy+13,953.28$8.98$125.30K171,191
Douglas S. Prince
Director
Jul 1, 2026Award+1,515$5.36$8.12K69,331
Douglas A. Roeder
Director
Jul 1, 2026Award+2,751$5.36$14.75K157,238
Edward Fiorentino
Director
Jul 1, 2026Award+2,635$5.36$14.12K85,974
Edelman Steven
Director
Jul 1, 2026Award+2,402$5.36$12.87K91,083
Kenneth L. Horton
GC & Corp. Development Advisor
Jun 15, 2026Tax withholding−9,545$7.18$68.53K285,512
Frederick T. Sullivan
Chief Financial Officer
Jun 15, 2026Tax withholding−5,397$7.18$38.75K226,477
Brian B. Hansen
Chief Commercial Officer, Director
Jun 15, 2026Tax withholding−5,420$7.18$38.92K126,937
Mukul JAIN
Chief Operating Officer
Jun 15, 2026Tax withholding−16,194$7.18$116.27K500,863
Francine Kaufman
Chief Medical Officer, Director
Jun 15, 2026Tax withholding−4,010$7.18$28.79K177,057
Timothy T. Goodnow
President and CEO, Director
Jun 15, 2026Tax withholding−32,598$7.18$234.05K1,143,748
Douglas A. Roeder
Director
May 20, 2026Award+9,852––154,487
Douglas S. Prince
Director
May 20, 2026Award+9,852––67,816
Stephen P. DeFalco
Director
May 20, 2026Award+9,852––111,019
Edward Fiorentino
Director
May 20, 2026Award+9,852––83,339
Edelman Steven
Director
May 20, 2026Award+9,852––88,681
Sharon Larkin
Director
May 20, 2026Award+9,852––41,862
Brian B. Hansen
Chief Commercial Officer, Director
May 19, 2026Award+90,253––132,357
Francine Kaufman
Chief Medical Officer, Director
May 19, 2026Award+63,177––181,067
Mukul JAIN
Chief Operating Officer
May 19, 2026Award+270,759––517,057
Frederick T. Sullivan
Chief Financial Officer
May 19, 2026Award+90,253––231,874
Kenneth L. Horton
GC & Corp. Development Advisor
May 19, 2026Award+157,943––295,057
Timothy T. Goodnow
President and CEO, Director
May 19, 2026Award+553,701––1,176,346
Frederick T. Sullivan
Chief Financial Officer
May 15, 2026Tax withholding−9,005$5.82$52.41K141,621
Kenneth L. Horton
GC & Corp. Development Advisor
May 15, 2026Tax withholding−7,320$5.82$42.60K137,114
Mukul JAIN
Chief Operating Officer
May 15, 2026Tax withholding−13,681$5.82$79.62K246,298
Timothy T. Goodnow
President and CEO, Director
May 15, 2026Tax withholding−28,598$5.82$166.44K622,645
Francine Kaufman
Chief Medical Officer, Director
May 15, 2026Tax withholding−6,058$5.82$35.26K117,890
Douglas A. Roeder
Director
May 12, 2026Buy+22,686$5.56$126.13K144,635
Edelman Steven
Director
Apr 1, 2026Award+1,936$6.65$12.87K78,829
Edward Fiorentino
Director
Apr 1, 2026Award+2,124$6.65$14.12K73,487
Douglas A. Roeder
Director
Apr 1, 2026Award+2,218$6.65$14.75K121,949
Douglas S. Prince
Director
Apr 1, 2026Award+1,221$6.65$8.12K57,964
Timothy T. Goodnow
President and CEO, Director
Mar 13, 2026Buy+17,225$5.79$99.73K651,243
Douglas A. Roeder
Director
Mar 13, 2026Buy+17,500$5.73$100.28K119,731
Douglas A. Roeder
Director
Jan 2, 2026Award+2,504$5.89$14.75K102,231
Douglas S. Prince
Director
Jan 2, 2026Award+1,379$5.89$8.12K56,743
Edward Fiorentino
Director
Jan 2, 2026Award+2,398$5.89$14.12K71,363
Edelman Steven
Director
Jan 2, 2026Award+2,185$5.89$12.87K76,893
Frederick T. Sullivan
Chief Financial Officer
Nov 15, 2025Tax withholding−6,402$6.26$40.08K150,626
Timothy T. Goodnow
President and CEO, Director
Nov 15, 2025Tax withholding−27,067$6.26$169.44K634,018
Mukul JAIN
Chief Operating Officer
Nov 15, 2025Tax withholding−10,317$6.26$64.58K259,979
Kenneth L. Horton
GC & Corp. Development Advisor
Nov 15, 2025Tax withholding−5,997$6.26$37.54K144,434
Francine Kaufman
Chief Medical Officer, Director
Nov 15, 2025Tax withholding−4,605$6.26$28.83K123,948
Edelman Steven
Director
Nov 10, 2025Buy+10,000$6.55$65.50K74,708
Timothy T. Goodnow
President and CEO, Director
Nov 7, 2025Buy−17,210$5.87$101.02K661,085
Frederick T. Sullivan
Chief Financial Officer
Nov 7, 2025Buy+5,415$5.88$31.84K157,028
Douglas A. Roeder
Director
Nov 7, 2025Buy+15,000$5.83$87.45K99,727
Douglas S. Prince
Director
Oct 1, 2025Award+19,673$0.41$8.07K1,107,280

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
9.51%
5M shares short
Days to cover
7.8
At 1M shares a day
Change since last report
-2.7%
From 5M shares
Short volume, 20 days
35.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Senseonics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,900 shares on Sep 4, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Sharon Larkin
Officer
Sep 7, 202330,889$19.15KSep 7, 2023Restricted Stock Units

See a number that looks wrong?